Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 29, Issue 3, 2008, Pages 209-217

  Craig, Timothy J ^a   Ferguson, Berrylin J ^b   Krouse, John H ^c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZELASTINE; BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MOMETASONE FUROATE; TRIAMCINOLONE ACETONIDE;

ALLERGIC RHINITIS; ARTICLE; CLINICAL RESEARCH; DAYTIME SOMNOLENCE; DISEASE ASSOCIATION; GENERAL CONDITION IMPROVEMENT; HAY FEVER; HUMAN; NOSE CONGESTION; NOSE POLYP; PERENNIAL RHINITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RHINOSINUSITIS; SLEEP DISORDER; SLEEP PATTERN; SLEEP TIME; THERAPY EFFECT; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

HUMANS; NASAL POLYPS; RHINITIS, ALLERGIC, PERENNIAL; SINUSITIS; SLEEP DISORDERS;

EID: 42749091322     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2007.06.002     Document Type: Article

References (120)

1. Blaiss M., Reigel T., and Philpot E. A study to determine the impact of rhinitis on sufferers' sleep and daily routine. J Allergy Clin Immunol 115 (2005) S197 [Abstr]
2. Kenny T.J., Duncavage J., Bracikowski J., et al. Prospective analysis of sinus symptoms and correlation with paranasal computed tomography scan. Otolaryngol Head Neck Surg 125 (2001) 40-43
3. Radenne F., Lamblin C., Vandezande L.M., et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 104 (1999) 79-84
4. D'Alonzo G.E. Scope and impact of allergic rhinitis. J Am Osteopath Assoc 102 (2002) S2-S6
5. Fokkens W., Lund V., Bachert C., et al., for EAACI: EAACI position paper on rhinosinusitis and nasal polyps. Executive summary. Allergy 60 (2005) 583-601
6. Bhattacharyya N. The economic burden and symptom manifestations of chronic rhinosinusitis. Am J Rhinol 17 (2003) 27-32
7. Suratt P.M., Turner B.L., and Wilhoit S.C. Effect of intranasal obstruction on breathing during sleep. Chest 90 (1986) 324-329
8. Millman R.P., Acebo C., Rosenberg C., et al. Sleep, breathing, and cephalometrics in older children and young adults. Part II-response to nasal occlusion. Chest 109 (1996) 673-679
9. Young T., Finn L., and Palta M. Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med 161 (2001) 1514-1519
10. Rappai M., Collop N., and Kemp S. The nose and sleep-disordered breathing. What we know and what we do not know. Chest 124 (2003) 2309-2323
11. Bachert C., van Cauwenberge P., and Khaltaev N. Allergic Rhinitis and its Impact on Asthma (ARIA). In collaboration with the World Health Organization. Executive summary of the workshop report. December 7-10, 1999; Geneva, Switzerland. Allergy 57 (2002) 841-855
12. Salib R.J., Drake-Lee A., and Howarth P.H. Allergic rhinitis: past, present and the future. Clin Otolaryngol 28 (2003) 291-303
13. Dykewicz M.S., Fineman S., Skoner D.P., et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 81 (1998) 478-518
14. Bauchau V., and Durham S.R. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 24 (2004) 758-764
15. Anand V.K. Epidemiology and economic impact of rhinosinusitis. Ann Otol Rhinol Laryngol 193 (2004) 3-5
16. Bachert C., Hormann K., Mosges R., et al. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 58 (2003) 176-191
17. Klossek J.M., Neukirch F., Pribil C., et al. Prevalence of nasal polyposis in France: a cross-sectional, case-control study. Allergy 60 (2005) 233-237
18. Johansson L., Akerlund A., Holmberg K., et al. Prevalence of nasal polyps in adults: the Skovde population-based study. Ann Otol Rhinol Laryngol 112 (2003) 625-629
19. Hedman J., Kaprio J., Poussa T., et al. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 28 (1999) 717-722
20. Stempel D.A., and Woolf R. The cost of treating allergic rhinitis. Curr Allergy Asthma Rep 2 (2002) 223-230
21. Leynaert B., Neukirch C., and Liard R. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med 162 (2000) 1391-1396
22. Bousquet J., Bullinger M., Fayol C., et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 94 (1994) 182-188
23. Juniper E. Quality of life in adults and children with asthma and rhinitis. Allergy 52 (1997) 971-977
24. Alobid I., Benítez P., Bernal-Sprekelsen M., et al. Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments. Allergy 60 (2005) 452-458
25. Blaiss M.S. Quality of life in allergic rhinitis. Ann Allergy Asthma Immunol 83 (1999) 449-454
26. Thompson A.K., Juniper E., and Meltzer E.O. Quality of life in patients with allergic rhinitis. Ann Allergy Asthma Immunol 85 (2000) 338-348
27. Meltzer E.O. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 108 (2001) S45-S53
28. Majani G., Baiardini I., Giardini A., et al. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy 56 (2001) 313-317
29. Ferguson B.J. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg 130 (2004) 617-629
30. American Academy of Allergy, Asthma and Immunology. The Allergy Report. Available at: http://www.theallergyreport.com/reportindex.html [Accessed April 20, 2006].
31. McNicholas W.T., Tarlo S., Cole P., et al. Obstructive sleep apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 126 (1982) 625-628
32. Staevska M.T., Mandajieva M.A., and Dimitrov V.D. Rhinitis and sleep apnea. Curr Allergy Asthma Rep 4 (2004) 193-199
33. Lavie P., Gertner R., Zomer J., et al. Breathing disorders in sleep associated with "microarousals" in patients with allergic rhinitis. Acta Otolaryngol 92 (1981) 529-533
34. Kramer M.F., De La Chaux R., Derher A., et al. Allergic rhinitis does not constitute a risk factor for obstructive sleep apnea syndrome. Acta Otolaryngol 121 (2001) 494-499
35. Young T., Finn L., and Kim H. The University of Wisconsin Sleep and Respiratory Research Group: nasal obstruction as a risk factor for sleep-disordered breathing. J Allergy Clin Immunol 99 (1997) S757-S762
36. Chng S.Y., Goh D.Y., Wang X.S., et al. Snoring and atopic disease: a strong association. Pediatr Pulmonol 38 (2004) 210-216
37. Sogut A., Altin R., Uzun L., et al. Prevalence of obstructive sleep apnea syndrome and associated symptoms in 3-11 year-old Turkish children. Pediatr Pulmonol 39 (2005) 251-256
38. McColley S.A., Carroll J.L., Curtis S., et al. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 111 (1997) 170-173
39. Janson C., De Backer W., Gislason T., et al. Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries. Eur Respir J 9 (1996) 2132-2138
40. Serrano E., Neukirch F., Pribil C., et al. Nasal polyposis in France: impact on sleep and quality of life. J Laryngol Otol 119 (2005) 543-549
41. Chester A.C. Symptoms of rhinosinusitis in patients with unexplained chronic fatigue or bodily pain: a pilot study. Arch Intern Med 163 (2003) 1832-1836
42. Craig T.J., McCann J.L., Gurevich F., et al. The correlation between allergic rhinitis and sleep disturbance. J Allergy Clin Immunol 114 (2004) S139-S145
43. Craig T.J., Teets S., Lehman E.B., et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol 101 (1998) 633-637
44. Stuck B.A., Czajkowski J., Hagner A.E., et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol 113 (2004) 663-668
45. Corey J.P., Houser S.M., Ng B.A. Nasal congestion: a review of its etiology, evaluation, and treatment. Ear Nose Throat J 2000;79:690-693, 696, 698.
46. Jessen M., and Malm L. Definition, prevalence and development of nasal obstruction. Allergy 52 (1997) 3-6
47. Nathan R.A., Eccles R., Howarth P.H., et al. Objective monitoring of nasal patency and nasal physiology in rhinitis. J Allergy Clin Immunol 115 (2005) S442-S459
48. Houser S.M., Mamikoglu B., Aquino B.F., et al. Acoustic rhinometry findings in patients with mild sleep apnea. Otolaryngol Head Neck Surg 126 (2002) 475-480
49. Mamikoglu B., Houser S.M., and Corey J.P. An interpretation method for objective assessment of nasal congestion with acoustic rhinometry. Laryngoscope 112 (2002) 926-929
50. Rundcrantz H. Postural variations of nasal patency. Acta Otolaryngol 68 (1969) 435-443
51. Landstra A.M., Postma D.S., Boezen H.M., et al. Role of serum cortisol levels in children with asthma. Am J Respir Crit Care Med 165 (2002) 708-712
52. Reinberg A., Gervais P., Levi F., et al. Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiologic methods. J Allergy Clin Immunol 81 (1988) 51-62
53. Impact of nasal congestion among allergic rhinitis sufferers. An internet survey of 2002 people. Roper Public Affairs Group of NOP World; New York, NY; May-June 2004
54. Juniper E.F., Rohrbaugh T., and Meltzer E.O. A questionnaire to measure quality of life in adults with nocturnal allergic rhinoconjunctivitis. J Allergy Clin Immunol 111 (2003) 484-490
55. Canova C.R., Downs S.H., Knoblauch A., et al. Increased prevalence of perennial allergic rhinitis in patients with obstructive sleep apnea. Respiration 71 (2004) 138-143
56. Chen W., and Kushida C.A. Nasal obstruction in sleep-disordered breathing. Otolaryngol Clin North Am 36 (2003) 437-460
57. Storms W.W. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol 114 (2004) S146-S153
58. Camhi S.L., Morgan W.J., Pernisco N., et al. Factors affecting sleep disturbances in children and adolescents. Sleep Med 1 (2000) 117-123
59. Tashiro M., Mochizuki H., Iwabuchi K., et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci 72 (2002) 409-414
60. Mullington J.M., Hinze-Selch D., and Pollmacher T. Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci 933 (2001) 201-210
61. Krouse H.J., Davis J.E., and Krouse J.H. Immune mediators in allergic rhinitis and sleep. Otolaryngol Head Neck Surg 126 (2002) 607-613
62. Aoyagi M., Watanabe H., Sekine K., et al. Circadian variation in nasal reactivity in children with allergic rhinitis: correlation with the activity of eosinophils and basophilic cells. Int Arch Allergy Immunol 120 (1999) 95-99
63. Marshall P.S., O'Hara C., and Steinberg P. Effects of seasonal allergic rhinitis on selected cognitive abilities. Ann Allergy Asthma Immunol 84 (2000) 403-410
64. Wilken J.A., Berkowitz R., and Kane R. Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitis. Ann Allergy Asthma Immunol 89 (2002) 372-380
65. Kessler R.C., Almeida D.M., Berglund P., et al. Pollen and mold exposure impairs the work performance of employees with allergic rhinitis. Ann Allergy Asthma Immunol 87 (2001) 289-295
66. Vuurman E.F., van Veggel L.M., Uiterwijk M.M., et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy 71 (1993) 121-126
67. International Conference on Allergic Rhinitis in Childhood: allergic rhinitis in childhood. Allergy 54 (1999) 7-34
68. Lack G. Pediatric allergic rhinitis and comorbid disorders. J Allergy Clin Immunol 108 (2001) S9-S15
69. Simons F.E. Learning impairment and allergic rhinitis. Allergy Asthma Proc 17 (1996) 185-189
70. Flemons W.W., and Tsai W. Quality of life consequences of sleep-disordered breathing. J Allergy Clin Immunol 99 (1997) S750-S756
71. Martin S.E., Engleman H.M., Deary I.J., et al. The effect of sleep fragmentation on daytime function. Am J Respir Crit Care Med 153 (1996) 1328-1332
72. Martin S.E., Wraith P.K., Deary I.J., et al. The effect of nonvisible sleep fragmentation on daytime function. Am J Respir Crit Care Med 155 (1997) 1596-1601
73. Juniper E.F., Guyatt G.H., and Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 93 (1994) 413-423
74. Fisher L., Ghaffari G., Davies M., et al. Effects of poor sleep in allergic rhinitis. Curr Opin Allergy Clin Immunol 5 (2005) 11-16
75. Understanding the dynamics surrounding allergy suffering and treatment: global results. The Forbes Consulting Group; Lexington, Mass; September 2005
76. Spaeth J., Klimek L., and Mosges R. Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment. Allergy 51 (1996) 893-906
77. Kremer B., den Hartog H.M., and Jolles J. Relationship between allergic rhinitis, disturbed cognitive functions and psychological well-being. Clin Exp Allergy 32 (2002) 1310-1315
78. Juniper E.F., and Guyatt G.H. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 21 (1991) 77-83
79. Juniper E.F., Ståhl E., Doty R.L., et al. Clinical outcomes and adverse effect monitoring in allergic rhinitis. J Allergy Clin Immunol 115 (2005) S390-S413
80. Piccirillo J., Edwards D., Haiduk A., et al. Psychometric and clinimetric validity of the 31-item rhinosinusitis outcome measure (RSOM-31). Am J Rhinol 9 (1995) 297-306
81. Piccirillo J.F., Merritt M.G., and Richards M.L. Psychometric and clinimetric validity of the 20-item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg 126 (2002) 41-47
82. Gliklich R.E., and Metson R. Techniques for outcomes research in chronic sinusitis. Laryngoscope 105 (1995) 387-390
83. Benninger M.S., and Senior B.A. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg 123 (1997) 1175-1179
84. Johns M.W. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14 (1991) 540-545
85. Buysse D.J., Reynolds III C.F., Monk T.H., et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28 (1989) 193-213
86. Flemons W.W., and Reimer M.A. Measurement properties of the Calgary Sleep Apnea Quality of Life Index. Am J Respir Crit Care Med 165 (2002) 159-164
87. Weaver T.E., Laizner A.M., Evans L.K., et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 20 (1997) 835-843
88. Mansfield L.E., Diaz G., Posey C.R., et al. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol 92 (2004) 240-244
89. Craig T.J., Mende C., Hughes K., et al. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc 24 (2003) 53-58
90. Murray J.J., Nathan R.A., Bronsky E.A., et al. Comprehensive evaluation of cetirizine in the management of seasonal allergic rhinitis: impact on symptoms, quality of life, productivity, and activity impairment. Allergy Asthma Proc 23 (2002) 391-398
91. Golden S., Teets S.J., Lehman E.B., et al. Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Ann Allergy Asthma Immunol 85 (2000) 53-57
92. McLean H.A., Urton A.M., Driver H.S., et al. Effect of treating severe nasal obstruction on the severity of obstructive sleep apnea. Eur Respir J 25 (2005) 521-527
93. Milgrom H., Biondi R., Georgitis J.W., et al. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol 83 (1999) 105-111
94. Goldbart A.D., Goldman J.L., Veling M.C., et al. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 172 (2005) 364-370
95. Ohta N., Sakuri S., Yoshitake H., et al. Study of the effects of anti-leukotriene receptor antagonists on chronic allergic rhinitis using QOL as an index. Presented at: World Allergy Congress; June 26-July 1, Munich, Germany (2005)
96. Moinuddin R., deTineo M., Maleckar B., et al. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 92 (2004) 73-79
97. Tuncer U., Soylu L., Aydogan B., et al. The effectiveness of steroid treatment in nasal polyposis. Auris Nasus Larynx 30 (2003) 263-268
98. Dalziel K., Stein K., Round A., et al. Systematic review of endoscopic sinus surgery for nasal polyps. Health Technol Assess 7:iii (2003) 1-159
99. Ragab S.M., Lund V.J., and Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomized, controlled trial. Laryngoscope 114 (2004) 923-930
100. van Cauwenberge P., Bachert C., Passalacqua G., et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 55 (2000) 116-134
101. Bousquet J., van Cauwenberge P., Khaltaev N., and ARIA Workshop Group. World Health Organization: Allergic Rhinitis and its Impact on Asthma (ARIA). J Allergy Clin Immunol 108 (2001) S147-S334
102. Gawchik S., Goldstein S., Prenner B., et al. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray. Ann Allergy Asthma Immunol 90 (2003) 416-421
103. Mandl M., Nolop K., and Lutsky B.N. 194-079 Study Group: comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. Ann Allergy Asthma Immunol 79 (1997) 370-378
104. Meltzer E.O., Staudinger H., Bloom M., et al. Efficacy of once-daily mometasone furoate in patients with seasonal allergic rhinitis and severe nasal congestion. Presented at: World Allergy Congress; June 26-July 1, Munich, Germany (2005) [abstr 710]
105. Meltzer E.O., Stjarne P., Bloom M., et al. Efficacy and safety of once-daily mometasone furoate in patients with nasal polyposis. Presented at: World Allergy Congress; June 26-July 1, Munich, Germany (2005)
106. Bloom M., and Staudinger H. Effect of mometasone furoate nasal spray (MFNS) on nasal polyposis. J Allergy Clin Immunol 113 (2004) S282 [Abstr 1027]
107. Nayak A.S., Settipane G.A., Pedinoff A., et al., Nasonex Sinusitis Group. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol 89 (2002) 271-278
108. Meltzer E.O., Bachert C., Rikken G., et al. Efficacy and safety of 200 μg OD or 200 μg BID mometasone furoate nasal spray vs amoxicillin vs placebo in the treatment of acute rhinosinusitis. Presented at: XXIII European Academy of Allergology and Clinical Immunology Congress; June 12-16, Amsterdam, The Netherlands (2004)
109. Meltzer E.O., Bachert C., and Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 116 (2005) 1289-1295
110. Bende M., Carrillo T., Vóna I., et al. A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis. Ann Allergy Asthma Immunol 88 (2002) 617-623
111. Wilson A.M., Orr L.C., Sims E.J., et al. Effects of monotherapy with intra-nasal corticosteroid or combined oral antihistamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 31 (2001) 61-68
112. Hughes K., Glass C., Ripchinski M., et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy 58 (2003) 380-385
113. Craig T.J., Gurevich F., Glass C., et al. The effect of intranasal steroid budesonide on sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. J Allergy Clin Immunol 113 (2004) S332 [Abstr 1227]
114. Kamenov S., Kamenov B., Moskovljevic J., et al. Intranasal budesonide treatment of rhino-sinusitis improves quality of life in school children. Presented at: World Allergy Congress; June 26-July 1, Munich, Germany (2005)
115. Berlin J.M., Golden S.J., Teets S., et al. Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J Am Osteopath Assoc 100 (2000) 8-13
116. Bender B.G., and Milgrom H. Comparison of the effects of fluticasone propionate aqueous nasal spray and loratadine on daytime alertness and performance in children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 92 (2004) 344-349
117. Kiely J.L., Nolan P., and McNicholas W.T. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax 59 (2004) 50-55
118. Potter P.C., Van Niekerk C.H., and Schoeman H.S. Effects of triamcinolone on quality of life in patients with persistent allergic rhinitis. Ann Allergy Asthma Immunol 91 (2003) 368-374
119. Mintz M., Garcia J., Diener P., et al. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol 92 (2004) 255-261
120. Bachert C., Meltzer E.O., Staudinger H., et al. Effect of mometasone furoate on the health-related quality of life of patients with acute rhinosinusitis. Presented at: World Allergy Congress; June 26-July 1, Munich, Germany (2005)